ORTHOPAEDIC FELLOWSHIP FACULTY

Hiroyuki SugayaCEO, TSOC Medical Corporation; President, Tokyo Sports & Orthopaedic Clinic · Tokyo Sports & Orthopaedic Clinic

Shoulder and elbow surgery, sports injuries and clinical outcomes research

EDITORIAL SUMMARY

About Hiroyuki Sugaya

TSOC states that Dr Sugaya led the Funabashi shoulder and elbow team for 18 years and has accepted many domestic and international fellows and visitors. The source identifies Hiroyuki Sugaya as CEO, TSOC Medical Corporation; President, Tokyo Sports & Orthopaedic Clinic at Tokyo Sports & Orthopaedic Clinic. The published clinical or academic focus includes Shoulder and elbow surgery, sports injuries and clinical outcomes research. Published qualifications include MD.

Within OrthoFellow, Hiroyuki Sugaya is connected to 1 current programme: TSOC International Shoulder & Elbow Fellowship / Visitor Programme. These links come from named faculty or programme-lead associations in the cited programme records; they are not inferred from specialty, publication history or geographic proximity.

The associated opportunities span Shoulder & Elbow across Japan, with clinical fellowship represented. Applicants should open each programme profile separately because faculty involvement does not by itself confirm a current application window, clinical privileges, funding, eligibility or direct supervision for a future intake.

This editorial page summarises source-backed professional and programme relationships already published in OrthoFellow. It does not reproduce an institutional biography or claim endorsement by Hiroyuki Sugaya. The official individual profile remains the primary source for current appointments and credentials, while each linked programme profile records its own evidence, status and verification date.

Appointments and faculty rosters can change. The official individual profile and programme source remain authoritative.

PROGRAMME CONNECTIONS

Fellowships and training associated with Hiroyuki Sugaya

Each programme keeps its own application status, deadline, eligibility, funding and evidence trail.